Hair Analysis for Drugs of Abuse. V. The Facility in Incorporation of Cocaine into Hair over Its Major Metabolites, Benzoylecgonine and Ecgonine Methyl Ester
Overview
Authors
Affiliations
We studied the incorporation of cocaine (COC), benzoylecgonine (BE) and ecgonine methyl ester (EME) into hair from blood. At first, the time courses of three drugs in rat plasma following i.p. administration of cocaine were investigated over 360 min. AUCs of COC, BE and EME in plasma were 14.2, 60.7 and 53.4 micrograms/ml/min, respectively. In contrast, the concentrations of the three compounds in hair were 16.4, 1.7 and 0.8 ng/mg. In spite of that, the AUC of COC in plasma was much lower than that of the other two compounds in plasma, the concentration of COC in hair was much higher than that of the other two compounds. The incorporation of COC into hair was much greater than that of BE and EME. If the incorporation of drugs from blood into hair is compared by [concentration in hair]/[AUC in plasma], that of COC, BE and EME is represented by 77:1.9:1. Our results suggest that the incorporation of drugs into hair from blood unexpectedly depends upon the physical properties of each drug.
Identification of 2C-B in Hair by UHPLC-HRMS/MS. A Real Forensic Case.
Matey J, Lopez-Fernandez A, Garcia-Ruiz C, Montalvo G, Zapata F, Martinez M Toxics. 2021; 9(7).
PMID: 34357913 PMC: 8309701. DOI: 10.3390/toxics9070170.
Kirla K, Groh K, Poetzsch M, Banote R, Stadnicka-Michalak J, Eggen R Front Pharmacol. 2018; 9:414.
PMID: 29755353 PMC: 5932571. DOI: 10.3389/fphar.2018.00414.
Zyoud S, Waring W, Al-Jabi S, Sweileh W Subst Abuse Treat Prev Policy. 2017; 12(1):6.
PMID: 28153037 PMC: 5290655. DOI: 10.1186/s13011-017-0090-9.
Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort.
Joya X, Gomez-Culebras M, Callejon A, Friguls B, Puig C, Ortigosa S BMC Pregnancy Childbirth. 2012; 12:2.
PMID: 22230295 PMC: 3277455. DOI: 10.1186/1471-2393-12-2.
A follow-up study of heroin addicts (VEdeTTE2): study design and protocol.
Vigna-Taglianti F, Mathis F, Diecidue R, Burroni P, Iannaccone A, Lampis F Subst Abuse Treat Prev Policy. 2007; 2:9.
PMID: 17362515 PMC: 1838901. DOI: 10.1186/1747-597X-2-9.